Prophylaxis of fungal infections
- PMID: 9476504
- DOI: 10.1111/j.1439-0507.1997.tb00563.x
Prophylaxis of fungal infections
Abstract
Considering the high morbidity and mortality of deep-seated opportunistic mycoses in severely immunosuppressed patients, strategies for prophylaxis appear to be indicated. Exposure to Aspergillus spp. can be prevented by air filtration which has been shown to reduce the rate of infection. However, Candida infections are predominantly caused by colonizing fungi; therefore drug prophylaxis is more promising. Prospective randomized studies proved the effectiveness of fluconazole (FLU) to prevent infections in patients after bone marrow transplantation.
Similar articles
-
[Prophylaxis against mycoses in neutropenic patients].Mycoses. 1994;37 Suppl 2:70-6. Mycoses. 1994. PMID: 7541892 Review. German.
-
Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.Pharmacotherapy. 1998 May-Jun;18(3):549-64. Pharmacotherapy. 1998. PMID: 9620106 Review.
-
Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole.Braz J Med Biol Res. 2002 Jul;35(7):789-98. doi: 10.1590/s0100-879x2002000700005. Braz J Med Biol Res. 2002. PMID: 12131918
-
Antifungal prophylaxis during neutropenia and immunodeficiency.Clin Microbiol Rev. 1997 Jul;10(3):477-504. doi: 10.1128/CMR.10.3.477. Clin Microbiol Rev. 1997. PMID: 9227863 Free PMC article. Review.
-
[Prophylaxis and therapy of fungal infections with fluconazole in patients after bone marrow transplantation].Mycoses. 1990;33 Suppl 1:19-26. Mycoses. 1990. PMID: 2101860 German.
Cited by
-
Current management of fungal infections.Drugs. 2001;61 Suppl 1:13-25. doi: 10.2165/00003495-200161001-00002. Drugs. 2001. PMID: 11219547 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous